共 50 条
- [1] Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 yearsBREAST CANCER RESEARCH, 2022, 24 (01)Fernandez, GerardoPrastawa, MarcelMadduri, Abishek SainathScott, RichardMarami, BahramShpalensky, NinaCascetta, KrystalSawyer, MaryChan, MonicaKoll, GiovanniShtabsky, AlexanderFeliz, AaronHansen, ThomasVeremis, BrandonCordon-Cardo, CarlosZeineh, JackDonovan, Michael J.
- [2] Development and Validation of a Digital-Artificial Intelligent (AI) enabled Assay to predict early-stage breast cancer recurrenceEUROPEAN JOURNAL OF CANCER, 2022, 175 : S85 - S85Fernandez, G.Prastawa, M.Scott, R.Marami, B.Shpalensky, N.Madduri, A.Cascetta, K.Sawyer, M.Chan, M.Koll, G.Malinowski, D.De Angel, R.Shtabsky, A.Feliz, A.Hansen, T.Veremis, B.Cordon-Cardo, C.Zeineh, J.Donovan, M.
- [3] External validation of an AI-enabled digital test (PreciseDx Breast) to predict breast cancer recurrence within 6-years exhibited good independent performance on a comparable early-stage cohort from the NetherlandsANNALS OF ONCOLOGY, 2024, 35 : S335 - S335Donovan, M. J.Westenend, P.Meurs, C.Fernandez, G.Zeineh, J.Madduri, A. SainathFeliz, A.Shtabsky, A.Zhang, X.Veremis, B.Deangel, R.Mejias, J. C.
- [4] Clinical validation of an Artificial-intelligent (AI) enabled digital test using the patients diagnostic breast biopsy to predict invasive breast cancer recurrence within 6-yearsEUROPEAN JOURNAL OF CANCER, 2024, 200 : 99 - 99Donovan, M.Fernandez, G.Zeineh, J.Madduri, A. SainathScott, R.Prastawa, M.
- [5] Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast CancerCLINICAL BREAST CANCER, 2024, 24 (02) : 93 - 102.e6Fernandez, GerardoZeineh, JackPrastawa, MarcelScott, RichardMadduri, Abishek SainathShtabsky, AlexanderJaffer, ShabnamFeliz, AaronVeremis, BrandonMejias, Juan CarlosCharytonowicz, ElizabethGladoun, NataliyaKoll, GiovanniCruz, KristianMalinowski, DougDonovan, Michael J.
- [6] AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancernpj Precision Oncology, 7Noorul WahabMichael TossIslam M. MiligyMostafa JahanifarNehal M. AtallahWenqi LuSimon GrahamMohsin BilalAbhir BhaleraoAyat G. LashenShorouk MakhloufAsmaa Y. IbrahimDavid SneadFayyaz MinhasShan E. Ahmed RazaEmad RakhaNasir Rajpoot
- [7] AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancerNPJ PRECISION ONCOLOGY, 2023, 7 (01)Wahab, NoorulToss, MichaelMiligy, Islam M.Jahanifar, MostafaAtallah, Nehal M.Lu, WenqiGraham, SimonBilal, MohsinBhalerao, AbhirLashen, Ayat G.Makhlouf, ShoroukIbrahim, Asmaa Y.Snead, DavidMinhas, FayyazRaza, Shan E. AhmedRakha, EmadRajpoot, Nasir
- [8] AI-enabled digital test to predict disease recurrence for patients with early-stage invasive breast cancer and performance in a MammaPrint low-risk cohort from the Netherlands with a median 6-year follow-upJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Donovan, Michael J.Meurs, ClaudiaFernandez, GerardoMadduri, Abishek SainathFeliz, AaronZeineh, JackDeAngel, RebeccaWestenend, Pieter
- [9] Prediction of early and late distant recurrence in early-stage breast cancer with Breast Cancer IndexJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Zhang, YiSchnabel, Catherine A.Schroeder, BrockJerevall, Piiha-LottaJankowitz, Rachel CatherineStal, OlleBrufsky, AdamSgroi, DennisErlander, Mark G.
- [10] Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast CancerCANCER, 2017, 123 (01) : 43 - 51Friese, Christopher R.Li, YunBondarenko, IrinaHofer, Timothy P.Ward, Kevin C.Hamilton, Ann S.Deapen, DennisKurian, Allison W.Katz, Steven J.